These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 17005652)

  • 1. Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies.
    Liu J; Ewald BA; Lynch DM; Nanda A; Sumida SM; Barouch DH
    J Virol; 2006 Dec; 80(24):11991-7. PubMed ID: 17005652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
    Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
    J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing an immunodominant epitope of hepatitis B surface antigen reveals an alternative repertoire of CD8 T cell epitopes of this viral antigen.
    Wieland A; Riedl P; Reimann J; Schirmbeck R
    Vaccine; 2009 Dec; 28(1):114-9. PubMed ID: 19818719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant canarypox vaccine-elicited CTL specific for dominant and subdominant simian immunodeficiency virus epitopes in rhesus monkeys.
    Santra S; Schmitz JE; Kuroda MJ; Lifton MA; Nickerson CE; Lord CI; Pal R; Franchini G; Letvin NL
    J Immunol; 2002 Feb; 168(4):1847-53. PubMed ID: 11823518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodomination in the evolution of dominant epitope-specific CD8+ T lymphocyte responses in simian immunodeficiency virus-infected rhesus monkeys.
    Newberg MH; McEvers KJ; Gorgone DA; Lifton MA; Baumeister SH; Veazey RS; Schmitz JE; Letvin NL
    J Immunol; 2006 Jan; 176(1):319-28. PubMed ID: 16365424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV.
    Hu X; Valentin A; Dayton F; Kulkarni V; Alicea C; Rosati M; Chowdhury B; Gautam R; Broderick KE; Sardesai NY; Martin MA; Mullins JI; Pavlakis GN; Felber BK
    J Immunol; 2016 Nov; 197(10):3999-4013. PubMed ID: 27733554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic conserved elements (CE) DNA vaccine induces strong T-cell responses against highly conserved viral sequences during simian-human immunodeficiency virus infection.
    Munson P; Liu Y; Bratt D; Fuller JT; Hu X; Pavlakis GN; Felber BK; Mullins JI; Fuller DH
    Hum Vaccin Immunother; 2018 Jul; 14(7):1820-1831. PubMed ID: 29648490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of T-cell receptor repertoire breadth to the dominance of epitope-specific CD8+ T-lymphocyte responses.
    Manuel ER; Charini WA; Sen P; Peyerl FW; Kuroda MJ; Schmitz JE; Autissier P; Sheeter DA; Torbett BE; Letvin NL
    J Virol; 2006 Dec; 80(24):12032-40. PubMed ID: 17035327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunodominance in virus-induced CD8(+) T-cell responses is dramatically modified by DNA immunization and is regulated by gamma interferon.
    Rodriguez F; Harkins S; Slifka MK; Whitton JL
    J Virol; 2002 May; 76(9):4251-9. PubMed ID: 11932390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominant CD8+ T-lymphocyte responses suppress expansion of vaccine-elicited subdominant T lymphocytes in rhesus monkeys challenged with pathogenic simian-human immunodeficiency virus.
    Manuel ER; Yeh WW; Seaman MS; Furr K; Lifton MA; Hulot SL; Autissier P; Letvin NL
    J Virol; 2009 Oct; 83(19):10028-35. PubMed ID: 19641002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4⁺ T cells, but few subdominant epitope-specific CD8⁺ T cells.
    Vojnov L; Bean AT; Peterson EJ; Chiuchiolo MJ; Sacha JB; Denes FS; Sandor M; Fuller DH; Fuller JT; Parks CL; McDermott AB; Wilson NA; Watkins DI
    Vaccine; 2011 Oct; 29(43):7483-90. PubMed ID: 21839132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
    Otahal P; Hutchinson SC; Mylin LM; Tevethia MJ; Tevethia SS; Schell TD
    J Immunol; 2005 Jul; 175(2):700-12. PubMed ID: 16002665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape.
    Loffredo JT; Burwitz BJ; Rakasz EG; Spencer SP; Stephany JJ; Vela JP; Martin SR; Reed J; Piaskowski SM; Furlott J; Weisgrau KL; Rodrigues DS; Soma T; Napoé G; Friedrich TC; Wilson NA; Kallas EG; Watkins DI
    J Virol; 2007 Mar; 81(6):2624-34. PubMed ID: 17192314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of TCRalphabeta combinations used by simian immunodeficiency virus-specific CD8+ T cells in rhesus monkeys: implications for CTL immunodominance.
    Hasegawa A; Moriya C; Liu H; Charini WA; Vinet HC; Subbramanian RA; Sen P; Letvin NL; Kuroda MJ
    J Immunol; 2007 Mar; 178(6):3409-17. PubMed ID: 17339435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques.
    Su J; Luscher MA; Xiong Y; Rustam T; Amara RR; Rakasz E; Robinson HL; MacDonald KS
    Int Immunol; 2005 May; 17(5):637-48. PubMed ID: 15824066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunodominant CD8 T cell response to the human cytomegalovirus tegument phosphoprotein pp65(495-503) epitope critically depends on CD4 T cell help in vaccinated HLA-A*0201 transgenic mice.
    Reiser M; Wieland A; Plachter B; Mertens T; Greiner J; Schirmbeck R
    J Immunol; 2011 Sep; 187(5):2172-80. PubMed ID: 21810614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-transduced dendritic cells injected into skin or lymph node prime potent simian immunodeficiency virus-specific T cell immunity in monkeys.
    Brown K; Gao W; Alber S; Trichel A; Murphey-Corb M; Watkins SC; Gambotto A; Barratt-Boyes SM
    J Immunol; 2003 Dec; 171(12):6875-82. PubMed ID: 14662894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys.
    Barouch DH; Craiu A; Santra S; Egan MA; Schmitz JE; Kuroda MJ; Fu TM; Nam JH; Wyatt LS; Lifton MA; Krivulka GR; Nickerson CE; Lord CI; Moss B; Lewis MG; Hirsch VM; Shiver JW; Letvin NL
    J Virol; 2001 Mar; 75(5):2462-7. PubMed ID: 11160750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice.
    Marsac D; Puaux AL; Rivière Y; Michel ML
    Immunobiology; 2005; 210(5):305-19. PubMed ID: 16164038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
    Riedl P; Wieland A; Lamberth K; Buus S; Lemonnier F; Reifenberg K; Reimann J; Schirmbeck R
    J Immunol; 2009 Jul; 183(1):370-80. PubMed ID: 19542448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.